Comprehensive Analysis of West Nile Virus–Specific T Cell Responses in Humans
Open Access
- 1 May 2008
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 197 (9) , 1296-1306
- https://doi.org/10.1086/586898
Abstract
BackgroundCellular responses have been shown to play a role in immune control and clearance of West Nile virus (WNV) in murine models. However, little is known about the immunogenic regions of the virus or the phenotype of responding T cells in human infection MethodsFrozen peripheral blood mononuclear cells (PBMCs) from 35 WNV-infected blood donors were screened for virus-specific T cell responses by an interferon-γ (IFN-γ) enzyme-linked immunosorbent spot assay that used 452 overlapping peptides spanning all WNV proteins. More-detailed phenotypic studies were performed on subjects with high-magnitude T cell responses ResultsIn individuals with identified responses, the total number of recognized WNV peptides ranged from 1 to 9 (median, 2 peptides), and the overall magnitude of responses ranged from 50 to 4210 spot-forming cells (SFCs) per 106 PBMCs (median, 130 SFCs/106 PBMCs). A subset of 8 frequently recognized peptides from the regions of the genome encoding membrane, envelope, and nonstructural 3 and 4b proteins was identified. Phenotypic study of the highest magnitude WNV-specific T cell responses revealed that most were mediated by CD8+ cells that expressed perforin and/or granzyme B ConclusionsThese findings are the first to define the breadth and characteristics of the human T cell response to WNV and have implications for candidate vaccine design and evaluationKeywords
This publication has 48 references indexed in Scilit:
- The Long-Term Outcomes of Human West Nile Virus InfectionClinical Infectious Diseases, 2007
- The molecular basis of antibody-mediated neutralization of West Nile virusExpert Opinion on Biological Therapy, 2007
- Virology, Pathology, and Clinical Manifestations of West Nile Virus DiseaseEmerging Infectious Diseases, 2005
- West Nile virus: where are we now?The Lancet Infectious Diseases, 2004
- Structure of West Nile VirusScience, 2003
- Innate and Adaptive Immune Responses Determine Protection against Disseminated Infection by West Nile Encephalitis VirusViral Immunology, 2003
- B Cells and Antibody Play Critical Roles in the Immediate Defense of Disseminated Infection by West Nile Encephalitis VirusJournal of Virology, 2003
- Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological surveyThe Lancet, 2001
- West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in miceArchiv für die gesamte Virusforschung, 1996
- Loss of active neuroinvasiveness in attenuated strains of West Nile virus: pathogenicity in immunocompetent and SCID miceArchiv für die gesamte Virusforschung, 1994